Your browser doesn't support javascript.
loading
A Phase Ib Open-Label, Multicenter Study of Inhaled DV281, a TLR9 Agonist, in Combination with Nivolumab in Patients with Advanced or Metastatic Non-small Cell Lung Cancer.
Garon, Edward B; Spira, Alexander I; Johnson, Melissa; Bazhenova, Lyudmila; Leach, Joseph; Cummings, Amy L; Candia, Albert; Coffman, Robert L; Janatpour, Mary J; Janssen, Robert; Gamelin, Erick; Chow, Laura Q M.
Afiliación
  • Garon EB; Department of Medicine, David Geffen School of Medicine at UCLA, Santa Monica, California. egaron@mednet.ucla.edu.
  • Spira AI; Department of Medicine, Virginia Cancer Specialists, Fairfax, Virginia.
  • Johnson M; Sarah Cannon Research Institute, Nashville, Tennessee.
  • Bazhenova L; Department of Medicine, UC San Diego, San Diego, California.
  • Leach J; Allina Health Virginia Piper Cancer Institute, Minneapolis, Minnesota.
  • Cummings AL; Department of Medicine, David Geffen School of Medicine at UCLA, Santa Monica, California.
  • Candia A; Dynavax Technologies Corporation, Emeryville, California.
  • Coffman RL; Dynavax Technologies Corporation, Emeryville, California.
  • Janatpour MJ; Dynavax Technologies Corporation, Emeryville, California.
  • Janssen R; Dynavax Technologies Corporation, Emeryville, California.
  • Gamelin E; Dynavax Technologies Corporation, Emeryville, California.
  • Chow LQM; Department of Medicine, University of Washington, Seattle, Washington.
Clin Cancer Res ; 27(16): 4566-4573, 2021 08 15.
Article en En | MEDLINE | ID: mdl-34108179

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Receptor Toll-Like 9 / Antineoplásicos Inmunológicos / Nivolumab Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Carcinoma de Pulmón de Células no Pequeñas / Receptor Toll-Like 9 / Antineoplásicos Inmunológicos / Nivolumab Tipo de estudio: Clinical_trials Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2021 Tipo del documento: Article